LISA CRARY: Open Payments
NPI 1376947424 · NEW BEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 33 payments from 6 companies in 2025. Trend: 2023 $189 · 2024 $476 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $202 |
| Alnylam Pharmaceuticals Inc. | 9 | $136 |
| Amgen Inc. | 5 | $118 |
| SCPHARMACEUTICALS INC. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Esperion Therapeutics, Inc. | 2 | $43 |
Products named: LEQVIO, Repatha, ONPATTRO, FUROSCIX, CAMZYOS, NEXLETOL, AMVUTTRA.
Industry payments across MA — which companies pay providers there.
